Results 161 to 170 of about 3,593,458 (250)

Synchronous Bilateral Breast Cancer: A Case Report Piloting and Evaluating the Implementation of the AI-Powered Large Language Model (LLM) ChatGPT. [PDF]

Cureus, 2023
Naik HR, Prather AD, Gurda GT.
europepmc   +1 more source

Impact of Isocenter Configuration and Flattening Filter Free Delivery on VMAT Planning for Synchronous Bilateral Breast Cancer. [PDF]

Int J Womens Health
Zhang J, Hong D, Gan Y, Chen Z.
europepmc   +1 more source

Dosimetric Comparison of Postmastectomy Radiotherapy Plans for Synchronous Bilateral Breast Cancer, Including Regional Lymph Node Irradiation. [PDF]

Technol Cancer Res Treat, 2023
Wu X, Huang J, Lin X, Zhang X, Lu H, Sun W, Duan S, Shi J, Huang X.   +8 more
europepmc   +1 more source

Gliomas with pleomorphic and pseudopapillary features (GPAP) are circumscribed tumors with targetable mutations, prolonged survival, and frequent tumor predisposition

Brain Pathology, EarlyView.
DNA methylation profiling identifies GPAP as a distinct circumscribed glioma with a characteristic expansive, multicystic radiological appearance, pleomorphic and pseudopapillary histology, a recognizable CNV profile, druggable molecular alterations, and recurrent cancer predisposition syndromes.
Alberto Picca, Valeria Barresi, Aude Trinquet, Luca Bertero, Lucia Nichelli, Guillaume Chotard, Michèle Bernier, Thomas Gareau, Salah Eddine Oussama Kacimi, Jaydutt Bhalshankar, Mathilde Filser, Julien Masliah‐Planchon, Marta Iollo, Henri Malaize, Bertrand Mathon, Luc Bauchet, Kifah Khouri, Besma Barka, Hélène Madry, Sabrina Rossi, Evelina Miele, Giuseppe Kenneth Ricciardi, Catherine Carpentier, Irina Coin, Marc Sanson, Mehdi Touat, Caroline Dehais, Alessia Pellerino, Roberta Rudà, Paola Cassoni, Valérie Rigau, Emmanuelle Uro‐Coste, Karima Mokhtari, Ahmed Idbaih, Patrick R. Benusiglio, Franck Bielle   +35 more
wiley   +1 more source

Bilateral Primary Breast Cancer: Current Evidence and Future Perspectives

Breast Cancer: Targets and Therapy
Huixi Zhong,1,2 Di Lu,1,2 Yaling Zeng,1,2 Xihui Tu,3 Purong Zhang,2 Tengfei Xing21School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610054, People’s Republic of China; 2Department of Breast, Sichuan Clinical ...
Zhong H, Lu D, Zeng Y, Tu X, Zhang P, Xing T   +5 more
doaj  

Early Distant Metastasis in Synchronous Bilateral Breast Cancer including a Small Low-Grade Carcinoma with Osteoclast-Like Giant Cells: A Case Report. [PDF]

Surg Case Rep
Hirata M, Morisaki T, Asaka Y, Matsuda H, Henmi S, Kikukawa Y, Kochi A, Watanabe C, Takada K, Tauchi Y, Ogisawa K, Kinoshita H, Kohashi K, Kashiwagi S.   +13 more
europepmc   +1 more source

Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer. [PDF]

J Appl Clin Med Phys, 2022
Kang SW, Kang S, Lee B, Song C, Eom KY, Jang BS, Kim IA, Kim JS, Cho W, Shin DS, Kim JY, Chung JB.   +11 more
europepmc   +1 more source

Lifestyle Management in Menopause: A Systematic Review of Women With Premature Ovarian Insufficiency

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Premature ovarian insufficiency (POI), the loss of ovarian function before age 40, increases the risk of cardiovascular disease, low bone mineral density, dementia and psychological distress. Lifestyle interventions reduce chronic disease risk in other populations and, with hormone therapy, may improve health outcomes in POI.
Ladan Yeganeh, Nathalie Vermeulen, Carolyn Ee, Helena Teede, Amanda J. Vincent   +4 more
wiley   +1 more source

Case Report: FAPI PET/CT detected occult contralateral DCIS and supraclavicular metastasis, guiding neoadjuvant therapy in synchronous bilateral breast cancer. [PDF]

Front Oncol
Cong L, Ji B, Gu Y, Wu Y, Wang W.
europepmc   +1 more source

Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management. [PDF]

Front Oncol, 2022
Quesada S, Fenoglietto P, Gourgou S, Lemanski C, Draghici R, Ailleres N, Prunaretty J, Azria D, Bourgier C.   +8 more
europepmc   +1 more source